MATTHEW AMAN: Open Payments
NPI 1366094435 · TROY, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$6,948 in 203 payments from 16 companies in 2025. Trend: 2023 $4,213 · 2024 $5,336 · 2025 $6,948
Food & beverage: $5,063Consulting: $1,740Education: $145
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 29 | $2,794 |
| Amgen Inc. | 68 | $1,164 |
| ABBVIE INC. | 39 | $778 |
| UCB, Inc. | 16 | $701 |
| GENZYME CORPORATION | 10 | $495 |
| Novartis Pharmaceuticals Corporation | 18 | $346 |
| GlaxoSmithKline, LLC. | 5 | $198 |
| AstraZeneca Pharmaceuticals LP | 3 | $136 |
| PFIZER INC. | 5 | $98 |
| ANI Pharmaceuticals, Inc. | 2 | $61 |
Products named: TREMFYA, Bimzelx, RINVOQ, KRYSTEXXA, KEVZARA, COSENTYX, OTEZLA, SKYRIZI.
Industry payments across MI — which companies pay providers there.
